Alzheimer's disease

Chips today, fog tomorrow? Study links processed foods to waning focus

Researchers in three universities have found that as the proportion of ultra-processed foods in a person’s diet increases, their performance on attention-based tasks decline.

Much-hyped Alzheimer’s drugs do not help patients, review finds

The review by the Cochrane organisation looked at drugs that target a plaque called amyloids which builds up in the brains of Alzheimer’s patients.

Paris engineer wins Picasso painting at charity auction – with $150 ticket

Mr Ari Hodara's ticket was picked at a ceremony in Paris that was livestreamed from auction house Christie’s.

New surgical procedure shown to improve symptoms of moderate Alzheimer’s disease

Clinical Assistant Professor Vincent Tay (left) and Clinical Assistant Professor Jeremy Sun hope to recruit an additional six patients this year as part of the trial’s next phase.

Music as medicine: Memory and speech are their everyday struggles – then they get to sing

Maartje de Lint, right, who leads the Singing Circle, a program for people with brain diseases or injuries, with participants at the Concertgebouw in Amsterdam, Jan. 21, 2026. At the Singing Circle in Amsterdam, people with cognitive decline join together to lift their spirits and improve their lives. (Ilvy Njiokiktjien/The New York Times)

Promising longevity molecule may help defend against Alzheimer’s disease: NUS Medicine study

jtaging - Dr Sheeja Navakkode and Prof Brian Kennedy, in the Healthy Longevity Translational Research Programme’s laboratory.

CREDIT: NUS MEDICINE

Walking a few thousand steps a day may reduce Alzheimer’s risk

A new study suggests exercise may be especially beneficial for older adults at higher risk of Alzheimer’s disease.

Could dementia patients benefit from an AI companion?

Experts say AI companions have the potential to help keep the brain active and alleviate loneliness in dementia patients, and to reduce the burden on caregivers.

Forum: Explore safer, cost-effective treatments for Alzheimer’s disease

Simply Science

What to know about 2 new Alzheimer’s disease drugs approved in Singapore

One factor that could stand in the way of wider acceptance of these drugs is their costliness.

E-paper

Newsletters

Podcasts

RSS Feed

About Us

Terms & Conditions

Personal Data Protection Notice

Need help? Reach us here.

Advertise with us

MDDI (P) 046/10/2025. Published by SPH Media Limited, Co. Regn. No.202120748H. Copyright © 2026 SPH Media Limited. All rights reserved.